Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–10 of 10 trials
Active filters
Clinical trials found
Published and searchable clinical trials
A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A
NCT06461533
- Conditions
- Acquired Hemophilia A, Factor 8 deficiency, acquired
- Locations
-
- Takeda selected site Tokyo, Japan
NCT06550882
- Conditions
- Acquired Hemophilia A, Factor 8 deficiency, acquired
- Locations
-
- Kyung Hee University Hospital at Gangdong Seoul, South Korea
- The Catholic University of Korea, Seoul St. Mary's Hospital Seoul, South Korea
- Ewha Womans University Medical Center Seoul, South Korea
- Ulsan University Hospital Ulsan, South Korea
NCT06727669
- Conditions
- Arterial Thromboembolism, Autoimmune Diseases, Bleeding Disorder, +45 more
- Locations
-
- Peking University Insititute of Hematology, Peking University People's Hospital Beijing, Beijing Municipality, China
- Department of Hematology, Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
- Department of Hematology, Beijing Hospital Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
NCT03384277
- Conditions
- Acquired Hemophilia A, Factor 8 deficiency, acquired
- Locations
-
- Ethics Committee of Blood disease hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
NCT04580407
- Conditions
- Acquired Hemophilia A, Factor 8 deficiency, acquired
- Locations
-
- Gunma University Hospital Maebashi, Gunma, Japan
- Nagoya University Hospital Aichi, Nagoya, Japan
- Nara Medical University Hospital Kashihara-shi, Nara, Japan
- Uonuma Kikan Hospital Minamiuonuma, Niigata, Japan
Emicizumab in Acquired Hemophilia A
NCT04188639
- Conditions
- Factor 8 deficiency, acquired, Hemophilia A, Acquired
- Locations
-
- Medizinische Universität Wien, Hämatologie/Hämostaseologie Wien, Lower Austria, Austria
- Medizinische Universitätsklinik Graz Graz, Styria, Austria
- Landeskrankenhaus Salzburg, Universitätsklinikum der PMU, Innere Med. III Salzburg, Austria
- LMU Klinikum, Hämophiliezentrum Erwachsene/Transfusionsmedizin München, Bavaria, Germany
NCT03199794
- Conditions
- Acquired Hemophilia A, Factor 8 deficiency, acquired
- Locations
-
- University of Florida - Shands Gainesville, Florida, United States
- Henry Ford Hospital Detroit, Michigan, United States
- Duke University Medical Center Durham, North Carolina, United States
- Cleveland Clinic Cleveland, Ohio, United States
NCT02610127
- Conditions
- Acquired Hemophilia A, Factor 8 deficiency, acquired
- Locations
-
- University of Colorado Health Aurora, Colorado, United States
- University of Florida Gainesville, Florida, United States
- Emory University School of Medicine Atlanta, Georgia, United States
- Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
NCT01178294
- Conditions
- Acquired Hemophilia A, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +8 more
- Locations
-
- Indiana Hemophilia and Thrombosis Center Indianapolis, Indiana, United States
- Louisiana Center for Bleeding & Clotting Disorders New Orleans, Louisiana, United States
- National Institutes of Health - Warren G. Magnuson Clinical Center Bethesda, Maryland, United States
- Tufts Medical Center Boston, Massachusetts, United States
Emicizumab in Patients With Acquired Hemophilia A
NCT05345197
- Conditions
- Acquired Hemophilia A, Factor 8 deficiency, acquired
- Locations
-
- UCSD Hemophilia and Thrombosis Treatment Center San Diego, California, United States
- Georgetown University Washington D.C., District of Columbia, United States
- Emory University Atlanta, Georgia, United States
- Bleeding and Clotting Disorders Institute Peoria, Illinois, United States